鸢尾素编码基因(FNDC5)多态性通过微小RNA差异结合3'UTR与非酒精性脂肪性肝病肝脂肪变相关
研究在987例白种人非酒精性脂肪性肝病(NAFLD)患者中,分析FNDC5基因3'UTR单核苷酸多态性rs3480与肝病严重程度及代谢指标的关系,并进行荧光素酶报告基因、等位基因特异性表达焦磷酸测序、血清鸢尾素检测和生物信息学等功能研究。结果rs3480(G)等位基因与更严重脂肪变相关(OR 1.29;95%CI 1.08-1.55;p=0.004),该作用独立于并叠加于PNPLA3和TM6SF2;机制涉及miR-135a-5P结合影响FNDC5 mRNA稳定性。
要点
- rs3480(G)等位基因与NAFLD患者更严重脂肪变相关(OR 1.29;95%CI 1.08-1.55;p=0.004),与其他组织学特征无关。
- 该效应独立于PNPLA3和TM6SF2,且与二者呈叠加作用。
- 血清鸢尾素升高与脂肪变减轻及代谢谱改善相关。
核心结论
- 携带FNDC5 rs3480次要(G)等位基因通过微小RNA介导的FNDC5 mRNA稳定性调控机制,与NAFLD更严重脂肪变相关。
- 鸢尾素可能对NAFLD具有有利的代谢影响。
研究设计与样本
- 在987例白种人NAFLD患者中研究rs3480与肝病严重程度及代谢谱的关联。
- 功能研究采用人FNDC5 3'UTR荧光素酶报告基因实验、肝脏FNDC5等位基因特异性表达焦磷酸测序、血清鸢尾素测定和生物信息学分析。
主要发现
- rs3480(G)等位基因与晚期脂肪变相关(OR 1.29;95%CI 1.08-1.55;p=0.004),与其他组织学特征无关。
- 该效应独立于PNPLA3和TM6SF2,且与二者呈叠加作用。
- rs3480多态性影响FNDC5 mRNA稳定性及miR-135a-5P结合;与对照相比,肝脏该微小RNA表达上调而FNDC5表达下调。
- 血清鸢尾素升高与脂肪变减轻及代谢谱改善相关。
关键数值与推荐
- rs3480(G)等位基因与晚期脂肪变相关:OR 1.29;95%CI 1.08-1.55;p=0.004。
- 该效应独立于PNPLA3和TM6SF2,且与二者呈叠加作用。
- rs3480多态性影响FNDC5 mRNA稳定性及miR-135a-5P结合,肝脏miR-135a-5P表达上调而FNDC5表达下调。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Irisin, the cleaved extra-cellular fragment of the Fibronectin type III domain-containing protein 5 (FNDC5) is a myokine that is proposed to have favorable metabolic activity. We aimed to elucidate the currently undefined role of variants in the FNDC5 gene in non-alcoholic fatty liver disease (NAFLD). METHODS: We prioritized single nucleotide polymorphisms in FNDC5 on the basis of their putative biological function and identified rs3480 in the 3' untranslated region (3'UTR). We studied the association of rs3480 with liver disease severity and the metabolic profile of 987 Caucasian patients with NAFLD. Functional investigations were undertaken using luciferase reporter assays of the 3'UTR of human FNDC5, pyrosequencing for allele-specific expression of FNDC5 in liver, measurement of serum irisin, and bioinformatics analysis. RESULTS: The rs3480 (G) allele was associated with advanced steatosis (OR 1.29; 95% CI 1.08-1.55; p = 0.004), but not with other histological features. This effect was independent but additive to PNPLA3 and TM6SF2. The rs3480 polymorphism influenced FNDC5 mRNA stability and the binding of miR-135a-5P. Compared with controls, hepatic expression of this microRNA was upregulated while FNDC5 expression was downregulated. Elevated serum irisin was associated with reduced steatosis, and an improved metabolic profile. CONCLUSIONS: Carriage of the FNDC5 rs3480 minor (G) allele is associated with more severe steatosis in NAFLD through a microRNA-mediated mechanism controlling FNDC5 mRNA stability. Irisin is likely to have a favorable metabolic impact on NAFLD. LAY SUMMARY: Irisin is a novel protein produced mainly by muscle, which is known to be released into the circulation, with an unclear role in liver fat deposition. This study demonstrates that genetic variants in the gene encoding the irisin protein modulate the risk of liver fat in patients with fatty liver disease. Interestingly, these effects are independent of, but additive to those of other recently described genetic variants that contribute to liver fat. In functional studies, we have deciphered the detailed molecular mechanisms by which this genetic variant mediates its effects.
引用
- Metwally M, Bayoumi A, Romero-Gomez M, et al. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. J Hepatol. 2018. PMID: 30389552. doi:10.1016/j.jhep.2018.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。